Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,627 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07019233 | A Study of the Effect of Real-time Pressure Controllers on Subjective and Objective Symptoms of Peripheral Neuropathy Induced by Albumin Paclitaxel | recruiting | N/A | 118 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Jun 13, 2025 | clinicaltrials |
| NCT07014410 | Pyrotinib Combined With Dalpiciclib Combined With Letrozole in ER-positive and HER2-positive Advanced Breast Cancer | recruiting | Phase 2 | 63 | Zhejiang Cancer HospitalOTHER | 1 | Jun 11, 2025 |
| clinicaltrials |
| NCT07012720 | Research on the Potential Mechanisms Underlying the Efficacy Differences in Specific Neoadjuvant Treatment Regimens for Different Subtypes of Breast Cancer | recruiting | N/A | 71 | Xijing HospitalOTHER | 1 | Jun 10, 2025 | clinicaltrials |
| NCT06515470 | Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BTX-9341 in Advanced and/or Metastatic Breast Cancer | recruiting | Phase 1 | 82 | Biotheryx, Inc.INDUSTRY | 1 | Jun 6, 2025 | clinicaltrials |
| NCT06596915 | Safety and Efficacy of BA1302 in Patients With Advanced Solid Tumors | recruiting | Phase 1 | 167 | Shandong Boan Biotechnology Co., LtdINDUSTRY | 1 | Jun 6, 2025 | clinicaltrials |
| NCT06678048 | Arsenous Acid for Refractory Triple-Negative Breast Cancer | recruiting | Phase 2 | 12 | Sun Yat-sen UniversityOTHER | 1 | Jun 6, 2025 | clinicaltrials |
| NCT06993714 | 3D-printed Biodegradable Breast Implants for Breast Restoration | recruiting | Phase 2 | 120 | Xijing HospitalOTHER | 1 | Jun 6, 2025 | clinicaltrials |
| NCT05740956 | A Study of Hansoh (HS)-10502 in Patients With Advanced Solid Tumors | recruiting | Phase 1 | 318 | Jiangsu Hansoh Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jun 5, 2025 | clinicaltrials |
| NCT06337214 | TCM Therapy Program Impact on Breast Cancer Patients' Vital Energy | recruiting | N/A | 80 | Taipei City HospitalOTHER_GOV | 1 | Jun 4, 2025 | clinicaltrials |
| NCT07003009 | Immun Checkpoint Washout in Patients With Invasive Ductal Breast Cancer | recruiting | N/A | 30 | Istanbul Training and Research HospitalOTHER_GOV | 1 | Jun 4, 2025 | clinicaltrials |
| NCT06672120 | Exercise in Triple- Negative Breast Cancer(ExACT-ICI) | recruiting | N/A | 120 | Technical University of MunichOTHER | 1 | May 31, 2025 | clinicaltrials |
| NCT06677879 | A Prospective Cohort Study of Proton and Photon Therapy for Left-sided Breast Cancer. | recruiting | Phase 2 | 780 | Shanghai Proton and Heavy Ion CenterOTHER | 1 | May 30, 2025 | clinicaltrials |
| NCT01793168 | Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford(CoRDS) | recruiting | — | 20,000 | Sanford HealthOTHER | 2 | May 29, 2025 | clinicaltrials |
| NCT04824027 | Breast Elasticity Imaging During Neoadjuvant Chemotherapy | recruiting | N/A | 50 | Columbia UniversityOTHER | 1 | May 29, 2025 | clinicaltrials |
| NCT06049355 | EMBRACE: Exercising Together | recruiting | Phase 2 | 400 | OHSU Knight Cancer InstituteOTHER | 1 | May 29, 2025 | clinicaltrials |
| NCT06991790 | Sacituzumab Govitecan + Toripalimab as First - Line Therapy for Advanced Triple - Negative Breast Cancer and Biomarker Exploration | recruiting | — | 51 | Peking University Cancer Hospital & InstituteOTHER | 1 | May 28, 2025 | clinicaltrials |
| NCT06991946 | Patient-Centric Study to Assess the Impact of Genomic Profiling on the Treatment of Patients With Metastatic Breast Cancer in Spain(HOPE-Focus) | recruiting | — | 300 | SOLTI Breast Cancer Research GroupOTHER | 1 | May 28, 2025 | clinicaltrials |
| NCT06992336 | Circulating Tumor DNA Guided Boost Therapy in Early Triple Negative Breast Patients With Residual Disease After Neoadjuvant Therapy | recruiting | Phase 2 | 411 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | May 28, 2025 | clinicaltrials |
| NCT06989450 | Digital Patient Support Program for Self-efficacy and Medication Adherence in Women on Adjuvant Endocrine Treatment for Breast Cancer | recruiting | N/A | 140 | Sidekick HealthINDUSTRY | 1 | May 25, 2025 | clinicaltrials |
| NCT05333328 | OFS in Premenopausal Node+ Breast Cancer With Low Genomic Risk(INTERSTELLAR) | recruiting | Phase 4 | 418 | Gangnam Severance HospitalOTHER | 1 | May 22, 2025 | clinicaltrials |
| NCT06984250 | Hypofractionated Radiotherapy With Concomitant Tumor Bed Boost for Breast Cancer(HFCBB) | recruiting | — | 315 | National Taiwan University HospitalOTHER | 1 | May 22, 2025 | clinicaltrials |
| NCT05999396 | FIH, Bispecific CD276xCD3 Antibody CC-3 in Patients With Colorectal Cancer(CoRe_CC-3) | recruiting | Phase 1 | 89 | German Cancer Research CenterOTHER | 1 | May 21, 2025 | clinicaltrials |
| NCT06915857 | Topical Betamethasone Versus Moisturizer in Preventing Radiation Dermatitis in Large-Breasted Patients Treated in the Prone Position | recruiting | Phase 3 | 276 | Sunnybrook Health Sciences CentreOTHER | 1 | May 21, 2025 | clinicaltrials |
| NCT06367088 | Cadonilimab Combined With Chemotherapy as First or Second Line Treatment in Recurrent or Metastatic Triple Negative Breast Cancer | recruiting | Phase 2 | 27 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 1 | May 20, 2025 | clinicaltrials |
| NCT03201861 | Addition of Cisplatin to Adjuvant Chemotherapy for Early Stage Breast Cancer in High-Risk Women | recruiting | Phase 3 | 762 | RenJi HospitalOTHER | 1 | May 16, 2025 | clinicaltrials |
| NCT04947189 | Seviteronel in Combination With Chemotherapy in Androgen-receptor Positive Metastatic Triple-negative Breast Cancer(4CAST) | recruiting | Phase 1 / Phase 2 | 65 | St Vincent's Hospital, SydneyOTHER | 1 | May 15, 2025 | clinicaltrials |
| NCT06165419 | Definitive Radiation for High-Risk Spine Metastases | recruiting | Phase 2 | 26 | Stony Brook UniversityOTHER | 1 | May 14, 2025 | clinicaltrials |
| NCT06970288 | Effectiveness of Introducing Ultra-High B-Value Diffusion-Weighted Imaging as a Modified Abbreviated Protocol for Breast Cancer Detection | recruiting | — | 85 | Ain Shams UniversityOTHER | 1 | May 14, 2025 | clinicaltrials |
| NCT05062707 | Early Ageing During Therapy in AYA Cancer Patients | recruiting | — | 120 | University Medical Center GroningenOTHER | 1 | May 13, 2025 | clinicaltrials |
| NCT06962670 | Predicting Cancer Risk With Digital and Molecular Markers(PräDigt) | recruiting | N/A | 1,250 | University of Erlangen-Nürnberg Medical SchoolOTHER | 1 | May 8, 2025 | clinicaltrials |
| NCT04261244 | NeoRad Breast Cancer Study(NeoRad) | recruiting | Phase 3 | 1,826 | Bielefeld UniversityOTHER | 1 | May 7, 2025 | clinicaltrials |
| NCT06958627 | The Impact of Intelligent Patient Management Model on Medication Adherence of Pyrotinib Compared to Traditional Patient Management Model: a Prospective, Multicenter, Randomized Controlled Clinical Study(any) | recruiting | Phase 2 / Phase 3 | 964 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | May 6, 2025 | clinicaltrials |
| NCT05621837 | Quantifying Systemic Immunosuppression to Personalize Cancer Therapy(Serpentine) | recruiting | — | 1,000 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | May 2, 2025 | clinicaltrials |
| NCT05658172 | Standard Surveillance vs. Intensive Surveillance in Early Breast Cancer(SURVIVE) | recruiting | N/A | 3,500 | Prof. Wolfgang JanniOTHER | 1 | May 2, 2025 | clinicaltrials |
| NCT06643585 | A Randomized Secondary Adjuvant Treatment Intervention Study Comparing Trastuzumab-Deruxtecan to SOC Therapy in eBC Patients With Molecular Relapse(SURVIVE HERoes) | recruiting | Phase 3 | 180 | Prof. Wolfgang JanniOTHER | 1 | May 2, 2025 | clinicaltrials |
| NCT04503265 | A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies | recruiting | Phase 1 / Phase 2 | 122 | AtlasMedx, IncorporatedINDUSTRY | 1 | May 1, 2025 | clinicaltrials |
| NCT04625023 | A Master Protocol Empowering Mechanobiology Translation Research in Breast Cancer(METAMECH) | recruiting | — | 1,500 | IFOM ETS - The AIRC Institute of Molecular OncologyOTHER | 1 | May 1, 2025 | clinicaltrials |
| NCT06207734 | Discontinuation of CDK4/6 Inhibitors in Patients With Metastatic HR Positive, HER2 Negative Breast Cancer | recruiting | Phase 2 | 120 | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus NordwestOTHER | 1 | May 1, 2025 | clinicaltrials |
| NCT05835570 | Integrin αvβ6-targeted PET in Malignant Tumors | recruiting | — | 200 | Zhongnan HospitalOTHER | 1 | Apr 30, 2025 | clinicaltrials |
| NCT06225284 | Neoadjuvant Chemotherapy With or Without GnRH Agonist for Premenopausal Triple-negative Early Breast Cancer Patients(ESCALATE) | recruiting | Phase 2 | 124 | National Taiwan University HospitalOTHER | 1 | Apr 29, 2025 | clinicaltrials |
| NCT06916338 | Clinical Study of 18F-Labeled FAPI-04 in PET Imaging of Breast Cancer | recruiting | — | 30 | The Affiliated Hospital of Qingdao UniversityOTHER | 1 | Apr 29, 2025 | clinicaltrials |
| NCT03824145 | Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer(EDC) | recruiting | N/A | 176 | Medical College of WisconsinOTHER | 1 | Apr 27, 2025 | clinicaltrials |
| NCT06947330 | Comparison Between Erector Spinae Plane Block Versus Serratus Anterior Plane Block Regarding Analgesia Post Modified Radical Mastectomy(FMASUMD66/2025) | recruiting | Phase 3 | 100 | Kholoud UsamaOTHER | 1 | Apr 27, 2025 | clinicaltrials |
| NCT05535413 | UTD1 Combined With Capecitabine in Metastatic HER2-negative Breast Cancer Patients With Brain Metastases | recruiting | Phase 1 / Phase 2 | 30 | Hunan Cancer HospitalOTHER | 1 | Apr 25, 2025 | clinicaltrials |
| NCT06476119 | OPTImaL:Optimisation of Treatment for Patients With Low Stage Triple-negative Breast Cancer With High Stromal Tumor-infiltrating Lymphocytes(OPTImaL) | recruiting | — | 490 | The Netherlands Cancer InstituteOTHER | 1 | Apr 23, 2025 | clinicaltrials |
| NCT06111417 | Use of an Ultra-rapid BRCA1/2 Status Screening Test in Diagnostic and Theranostic Indication: Performance and Interest for Patients and Practitioners(TURBO) | recruiting | — | 150 | Centre Georges Francois LeclercOTHER | 1 | Apr 22, 2025 | clinicaltrials |
| NCT06313983 | A Phase Ⅲ Study of Hemay022 in Combination With AI In Advanced Breast Cancer | recruiting | Phase 3 | 339 | Tianjin Hemay Pharmaceutical Co., LtdINDUSTRY | 1 | Apr 22, 2025 | clinicaltrials |
| NCT06938360 | Clinical Efficacy and Safety Assessment of Breast-Conserving Surgery for Central Breast Cancer: A Prospective Randomized Controlled Trial | recruiting | N/A | 158 | Xijing HospitalOTHER | 1 | Apr 22, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Jun 13, 2025source: clinicaltrials